(Q48078114)

8 February 2018

title

HIV-1 infection of monocytes is directly related to the success of HAART. (English)

1 reference

8 February 2018

author name string

Sharilyn Almodóvar

1

1 reference

8 February 2018

María Del C Colón

2

1 reference

8 February 2018

Irvin M Maldonado

3

1 reference

8 February 2018

Robert Villafañe

4

1 reference

8 February 2018

Silkha Abreu

5

1 reference

8 February 2018

Iván Meléndez

6

1 reference

8 February 2018

Carlos Domínguez

7

1 reference

8 February 2018

Wilfredo Cuevas

8

1 reference

8 February 2018

Timothy M Collins

9

1 reference

8 February 2018

Eric Lorenzo

10

1 reference

8 February 2018

language of work or name

English

0 references

publication date

16 August 2007

1 reference

8 February 2018

published in

Virology

1 reference

8 February 2018

volume

369

1 reference

8 February 2018

issue

1

1 reference

8 February 2018

page(s)

35-46

1 reference

8 February 2018

Abnormal cytokine production by circulating monocytes and dendritic cells of myeloid origin in ART-treated HIV-1+ patients relates to CD4+ T-cell recovery and HCV co-infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Down regulation of CD4 expression following isolation and culture of human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Application and accuracy of molecular phylogenies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

HIV production from purified monocytes isolated from antiretroviral-naïve and protease inhibitor-treated HIV-1-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

The Tat and C2-V3 envelope genes in the molecular epidemiology of human immunodeficiency virus-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Influence of CD4+ T cell counts on viral evolution in HIV-infected individuals undergoing suppressive HAART

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Genetic characterization of human immunodeficiency virus type 1 Tat before and after highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

HIV-1 sequence variation: drift, shift, and attenuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Antigenic Diversity Thresholds and the Development of AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Molecular epidemiology of HIV transmission in a dental practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

MODELTEST: testing the model of DNA substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Deletions in env gene of HIV-1 in AIDS patients treated with highly active antiretroviral therapy (HAART).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

The origin and kinetics of mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Antibody neutralization and escape by HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2007.07.010

1 reference

8 February 2018

PubMed ID

17707072

1 reference

8 February 2018